Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AGYS -11.9%, NXPI -6.2%, MMYT -3.8%, PM -3.8%, GM -3.6%, WRB -3.4%, GPC -3.1%, SHW -3%, RTX -2.4%, STLD -1.9%, PNR -1.8%, BOKF -1.5%, SYF -1.4%, DHR -1%, MSCI -0.9%
Other news:
- SFNC -5.4% (prices offering of 16.22 mln shares of common stock at $18.50 per share)
- KRMN -4.7% (files for 20 mln share offering by selling shareholders; also provides guidance)
- SSL -3.7% (reports FY25 sales and production)
- SRPT -2.9% (voluntarily pauses ELEVIDYS shipments in the US)
- ATGE -2.2% (CEO entered into a written trading plan to sell up to 108,000 shares of the Company's common stock)
- EW -1.4% (files mixed securities shelf offering)
- SAGE -1.3% (Biogen (BIIB) intends to tender all or a portion of SAGE common stock in the tender offer or to dispose of all or a portion of the common stock)
- AMPY -1.2% (announces an update on strategic initiatives and changes to the executive leadership team)
Analyst comments:
- BKSY -3.7% (downgraded to Hold from Buy at Clear Street)
- CRCL -2.7% (downgraded to Sell from Neutral at Compass Point)
- SHOP -2.4% (downgraded to Hold from Buy at Loop Capital)
- LULU -1.1% (downgraded to Neutral from Overweight at JPMorgan)